Skip to main content

Closed

VRTX: Vertex Pharmaceuticals Incorporated Financial Statements & Revenue | finqOS

Healthcare · Biotechnology

52W Range

67thpctl

Volume

0.61×avg

Market Cap

121.09BUSD

P/E Ratio

28.0TTM

Div Yield

-ann

Vertex Pharmaceuticals Incorporated

VRTXNASDAQ Global Select·USD·Closed

Vertex Pharmaceuticals Incorporated

VRTXNASDAQ·USD·Closed

$477.10

−0.95%

$477.10

−$4.60 (0.95%)

52W Range

67thpctl

Volume

0.61×avg

Mkt Cap

121.09BUSD

P/E

28.0TTM

Div Yield

–ann

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings

Overview Financials Peers Sentiment Analysis Transcripts Holders Company SEC Filings